SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Intel Corporation (INTC)
INTC 36.85+1.6%Dec 19 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe NYC who wrote (145360)10/15/2001 7:43:24 PM
From: Robert Salasidis  Read Replies (1) of 186894
 
The main problem is the possibility of developing resistance, or the half treatment of an actual exposure, with a delay in full treatment.

The incidence of things like other infections (Clostridium dificile for example) would be higher with rampant dosing, and the incidence of death from such diseases would be higher than the 1 case so far reported from Anthrax.

So I would agree with your statement.

It is the same as people driving 12 hrs to avoid flying, event though the 12 hour drive will have a higher mortality associated with it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News